(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XERIJECT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

XERIJECT

ST13

US500000090980394

Class

42

Filing

90980394

Registration

7197021

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

05/08/2025

Trademark type

Word

Nice classes

42

Filing date

12/04/2020

Registration date

10/17/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/17/2023

Last transaction

05/08/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2019-00-00

First use in commerce

2019-00-00

Drawing code

4

Owner type

03

Owner location

Chicago, IL

Examiner

NASSERGHODSI,SAHAR

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Xeris Pharmaceuticals, Inc.

Representatives

Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical research and development; pharmaceutical drug formulation and development services; providing information on drug technology platforms for the formulation and development of drugs and biologics

Publications

History of USPTO decisions and trademark events.

38 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/17/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/17/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/14/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/13/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/12/2023

DPCC

DIVISIONAL PROCESSING COMPLETE

09/12/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/30/2023

IUAF

USE AMENDMENT FILED

08/24/2023

DRRR

DIVISIONAL REQUEST RECEIVED

08/24/2023

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

08/24/2023

EISU

TEAS STATEMENT OF USE RECEIVED

08/24/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/02/2023

EX3G

SOU EXTENSION 3 GRANTED

01/31/2023

EXT3

SOU EXTENSION 3 FILED

01/31/2023

EEXT

SOU TEAS EXTENSION RECEIVED

01/31/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/23/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/31/2022

EX2G

SOU EXTENSION 2 GRANTED

05/27/2022

EXT2

SOU EXTENSION 2 FILED

05/27/2022

EEXT

SOU TEAS EXTENSION RECEIVED

05/27/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/19/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/18/2021

EX1G

SOU EXTENSION 1 GRANTED

12/16/2021

EXT1

SOU EXTENSION 1 FILED

12/16/2021

EEXT

SOU TEAS EXTENSION RECEIVED

12/16/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/24/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/29/2021

PUBO

PUBLISHED FOR OPPOSITION

06/29/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/09/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/26/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

05/26/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/26/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

05/26/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/26/2021

DOCK

ASSIGNED TO EXAMINER

05/24/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/12/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/10/2021

NWAP

NEW APPLICATION ENTERED

12/08/2020

Continuous trademark protection

Get notified about every new filing that threatens XERIJECT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.